TNBC Day 3.3.14-Educate to Empower

March 3rd is our second, annual TNBC Day (3.3.14), so I'm using my blog to share some interesting facts about Triple Negative Breast Cancer (TNBC).

• Triple negative breast cancer (TNBC) is one of many forms of breast cancer.

• Forms of breast cancer are generally diagnosed based on the presence or absence 
of three “receptors” known to fuel most breast cancer tumors: estrogen, progesterone and 
HER2-neu.

• A diagnosis of TNBC means that the tumor in question is estrogen-receptor negative, 
progesterone-receptor negative and Her2-negative. In other words, triple negative breast 
cancer tumors do not exhibit any of the three known receptors.

• Receptor-targeting therapies have fueled tremendous recent advances in the fight against breast cancer. Unfortunately, there is no such targeted therapy for triple negative breast cancer.

• TNBC tends to be more aggressive, more likely to recur, and more difficult to treat because there is no targeted treatment.

• TNBC disproportionately strikes younger women, women of African, Latina or Caribbean 
descent, and those with BRCA1 mutations.

• Approximately every half hour, another woman in the US is diagnosed with triple negative breast cancer.